English
Specials
    Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsBusinessMoneycontrol ResearchSupriya Lifescience IPO: A play on lower supply-chain risk for APIs

    Supriya Lifescience IPO: A play on lower supply-chain risk for APIs

    Supriya Lifescience's key strengths include 12 products, contributing to 67 percent of sales, which are backward integrated to the level of basic chemicals

    Anubhav Sahu
    December 16, 2021 / 10:02 IST
    Supriya Lifescience IPO: A play on lower supply-chain risk for APIs

    Supriya Lifescience IPO

    • PRO Panorama

      Moneycontrol Pro Panorama | GST rates cut, will consumption accelerate?

      Sep 4, 2025 / 03:05 PM IST

      For September 4 edition of Moneycontrol Pro Panorama: Indian stocks near fair value after global underperformance, inflation risks...

      Read Now
    Unlock This Article

    Are you a PRO subscriber? Sign In

    What Do You Get

    • Ad free Experience

      Seamless navigation, faster responses.

    • Expert Perspective

      Explore 230+ exclusive editorials every month

    • +

      Uncover Insights from World-Renowned Experts and Journalists

    • Actionable Insights

      40+ weekly investment ideas + 3 to 4 daily technical calls

    • Virtual Events

      Exclusive Live Webinars for Expert Trading & Investment Strategies!

    • Newsletters

      Stay ahead with daily and weekly insights

    View Offers

    Unlock exclusive discounts

    Disclosure & Disclaimer

    This Research Report / Research Recommendation has been published by Moneycontrol Dot Com India Limited (hereinafter referred to as “MCD”) which is a registered Investment Advisor under the Securities and Exchange Board of India (Investment Advisers) ...Read More